USD 4.71
(-7.83%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 100.0% |
2019 | -745.64 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2020 Q1 | 277.73 Thousand USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 FY | - USD | 100.0% |
2020 Q2 | - USD | -100.0% |
2019 Q1 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 FY | -745.64 Million USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
ADC Therapeutics SA | 16.17 Million USD | 100.0% |
Alto Neuroscience, Inc. | - USD | NaN% |
Biohaven Pharmaceutical Holding Company Ltd. | - USD | NaN% |
Ginkgo Bioworks Holdings, Inc. | 46 Thousand USD | 100.0% |
Nuvation Bio Inc. | - USD | NaN% |
Nuvation Bio Inc. | - USD | NaN% |
Arcus Biosciences, Inc. | - USD | NaN% |
Theriva Biologics, Inc. | - USD | NaN% |
Zymeworks Inc. | 1.00 USD | 100.0% |